Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial

For almost three decades in many countries azathioprine has been used to treat relapsing-remitting multiple sclerosis. However its efficacy was usually considered marginal and following approval of β interferons for this indication it was no longer recommended as first line treatment, even if presen...

Descripción completa

Detalles Bibliográficos
Autores principales: Massacesi, Luca, Tramacere, Irene, Amoroso, Salvatore, Battaglia, Mario A., Benedetti, Maria Donata, Filippini, Graziella, La Mantia, Loredana, Repice, Anna, Solari, Alessandra, Tedeschi, Gioacchino, Milanese, Clara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234663/
https://www.ncbi.nlm.nih.gov/pubmed/25402490
http://dx.doi.org/10.1371/journal.pone.0113371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234663/
https://www.ncbi.nlm.nih.gov/pubmed/25402490
http://dx.doi.org/10.1371/journal.pone.0113371

Ejemplares similares